The ICI Europe Summit, is not just another broad immuno-oncology meeting. Rather, it focuses specifically on the challenges that you and other drug developers face in advancing more checkpoint modulators into the market.

Through a combination of data-driven case studies and interactive experience sharing sessions, receive practical learning to advance your programmes.

Discover the latest insights into novel checkpoint pathways, more predictive preclinical models, optimal combination strategies and emerging stratification biomarkers.

Don’t miss this opportunity to join the leaders in the field, receive insights that will enable you to make the right decisions with your IO pipeline, and lay the foundations for your future success.